• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Bismuth, An Indispensable Component of Eradication Therapy].

作者信息

Song Kyung Ho

出版信息

Korean J Helicobacter Up Gastrointest Res. 2023 Jun;23(2):79-80. doi: 10.7704/kjhugr.2023.0028. Epub 2023 Jun 12.

DOI:10.7704/kjhugr.2023.0028
PMID:40502282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11967532/
Abstract
摘要

相似文献

1
[Bismuth, An Indispensable Component of Eradication Therapy].[铋，根除治疗中不可或缺的组成部分]
Korean J Helicobacter Up Gastrointest Res. 2023 Jun;23(2):79-80. doi: 10.7704/kjhugr.2023.0028. Epub 2023 Jun 12.
2
Efficacy of bismuth added to standard triple therapy as the first-line eradication regimen for Helicobacter pylori infection.铋剂四联疗法作为一线方案根除幽门螺杆菌感染的疗效。
Helicobacter. 2021 Jun;26(3):e12792. doi: 10.1111/hel.12792. Epub 2021 Mar 1.
3
Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicobacter pylori eradication.补充布拉氏酵母菌对铋剂四联疗法根除幽门螺杆菌的影响。
BMC Gastroenterol. 2025 Apr 18;25(1):273. doi: 10.1186/s12876-025-03879-y.
4
[The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication].[莫西沙星序贯治疗失败后含铋剂四联疗法根除幽门螺杆菌的疗效]
Korean J Gastroenterol. 2018 Apr 25;71(4):196-203. doi: 10.4166/kjg.2018.71.4.196.
5
Second-line bismuth-containing quadruple therapy for eradication and impact of diabetes.用于根除幽门螺杆菌及糖尿病影响的二线含铋四联疗法
World J Gastroenterol. 2017 Feb 14;23(6):1059-1066. doi: 10.3748/wjg.v23.i6.1059.
6
Efficacy of bismuth-based quadruple therapy for eradication of Helicobacter pylori infection based on previous antibiotic exposure: A large-scale prospective, single-center clinical trial in China.铋剂四联疗法根除幽门螺杆菌感染的疗效：基于既往抗生素暴露情况的一项中国大规模前瞻性单中心临床试验。
Helicobacter. 2020 Dec;25(6):e12755. doi: 10.1111/hel.12755. Epub 2020 Sep 11.
7
Antofloxacin-based bismuth quadruple therapy is safe and effective in Helicobacter pylori eradication: A prospective, open-label, randomized trial.基于安妥沙星的铋四联疗法在幽门螺杆菌根除中的安全性和有效性：一项前瞻性、开放标签、随机试验。
Arab J Gastroenterol. 2021 Mar;22(1):47-51. doi: 10.1016/j.ajg.2020.09.005. Epub 2021 Feb 5.
8
Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.序贯疗法与含阿莫西林/四环素的铋剂四联疗法一线根除幽门螺杆菌的比较：一项前瞻性、多中心、随机临床试验。
BMC Gastroenterol. 2016 Jul 26;16(1):79. doi: 10.1186/s12876-016-0490-8.
9
First-line Bismuth-containing Five-day Concomitant Quintuple Therapy for Helicobacter Pylori Eradication.一线含铋剂的五日联合五联疗法根除幽门螺杆菌
Helicobacter. 2016 Apr;21(2):100-5. doi: 10.1111/hel.12241. Epub 2015 Jun 23.
10
[Ten-day Sequential Therapy versus Bismuth Based Quadruple Therapy as Second Line Treatment for Helicobacter pylori Infection].[十天序贯疗法与铋剂四联疗法作为幽门螺杆菌感染二线治疗的对比研究]
Korean J Gastroenterol. 2015 Nov;66(5):261-7. doi: 10.4166/kjg.2015.66.5.261.

本文引用的文献

1
Bismuth-Based Quadruple Therapy versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Infection: A Multicenter Randomized Controlled Trial.铋剂四联疗法与甲硝唑强化三联疗法作为克拉霉素耐药感染一线治疗的比较：一项多中心随机对照试验。
Gut Liver. 2022 Sep 15;16(5):697-705. doi: 10.5009/gnl210365. Epub 2022 Feb 11.
2
Comparison of tailored eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial.韩国的个体化根除与改良铋四联疗法比较：一项随机对照试验。
Expert Rev Anti Infect Ther. 2022 Jun;20(6):923-929. doi: 10.1080/14787210.2022.2017280. Epub 2021 Dec 20.
3
Eradication According to Sequencing-Based 23S Ribosomal RNA Point Mutation Associated with Clarithromycin Resistance.基于与克拉霉素耐药相关的23S核糖体RNA点突变测序的根除治疗
J Clin Med. 2019 Dec 25;9(1):54. doi: 10.3390/jcm9010054.
4
An Economic Modeling Study of Eradication: Comparison of Dual Priming Oligonucleotide-Based Multiplex Polymerase Chain Reaction and Empirical Treatment.消除策略的经济模型研究：基于双重引物寡核苷酸的多重聚合酶链反应与经验性治疗的比较。
Gut Liver. 2018 Nov 15;12(6):648-654. doi: 10.5009/gnl18079.
5
Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients.基于导致克拉霉素耐药的 23S 核糖体 RNA 点突变的存在，为韩国患者量身定制的幽门螺杆菌根除策略的成本效益。
J Gastroenterol Hepatol. 2019 Apr;34(4):700-706. doi: 10.1111/jgh.14383. Epub 2018 Aug 2.